This report provides updated recommendations for managing the drug-drug interactions that occur when using antiretroviral therapy during TB treatment. Changes from previous versions of these guidelines include a summary of data from clinical trials regarding timing of antiretroviral therapy...
This information sheet uses a question and answer format to explain the CDC recommendations for HIV screening in TB clinics. It answers the questions: What are the recommendations for HIV screening in TB clinics, what is opt-out screening, why CDC recommends that TB clinics screen patients for...
This report summarizes 2011 guidelines or recommendations published by multiple agencies of the U.S. Department of Health and Human Services (DHHS) for prevention and control of HIV , viral hepatitis, STDs, and TB for persons who use drugs illicitly. It also summarizes existing evidence of...
This report from the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) describes its activities for the year 2008. It provides its history, mission, and key priorities, which are reducing health disparities, encouraging program collaboration and service integration...
This report summarizes the external consultation on appropriate key short - and long-term priorities for addressing social determinants of HIV/AIDS, viral hepatitis, sexually transmitted diseases (STDs), and tuberculosis (TB) for the National Center for HIV/AIDS, Viral Hepatitis, STD and TB...
This report is the annual compilation of data from World Health Organization’s (WHO) 193 member states. It provides a summary of the current status of national health and health systems, including mortality and burden of disease, causes of death, reported infectious diseases, health service...
This white paper outlines NCHHSTP’s strategic vision for program collaboration and service integration, building on and refining concepts.
This report describes approaches for managing patients with TB who are candidates for or who are undergoing protease inhibitor therapy and presents interim recommendations for managing these patients until additional data are available and formal guidelines are issued. Protease inhibitors...
